Corrigendum to: Association of nuclear factor-erythroid 2-related factor 2, thioredoxin interacting protein, and heme oxygenase-1 gene polymorphisms with diabetes and obesity in Mexican patients (Oxidative Medicine and Cellular Longevity (2016) 2016 (7367641) DOI: 10.1155/2016/7367641);Association of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Jiménez Osorio, Angélica Saraí ^a   González Reyes, Susana ^a   García Niño, Wylly Ramsés ^a   Moreno Macías, Hortensia ^b   Rodríguez Arellano, Martha Eunice ^c   Vargas Alarcón, Gilberto ^d   Zúñiga, Joaquín ^e   Barquera, Rodrigo ^f   Pedraza Chaverri, José ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

^c HOSPITAL REGIONAL LIC ADOLFO LÓPEZ MATEOS   (Mexico)

^d INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^e INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^f National School of Anthropology and History   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

NUTRITION; PORPHYRINS; PROTEINS;

GLUCOSE CONCENTRATION; HEME OXYGENASE-1; HEME OXYGENASE-1 GENE; HIGH-DENSITY LIPOPROTEIN CHOLESTEROLS; NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2; OXIDOREDUCTASES; RELATED FACTORS; TYPE-2 DIABETES;

GENES;

CREATININE; GENOMIC DNA; GLUCOSE; HEME OXYGENASE 1; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); THIOREDOXIN INTERACTING PROTEIN; TRANSCRIPTION FACTOR NRF2; BIOLOGICAL MARKER; CARRIER PROTEIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; HMOX1 PROTEIN, HUMAN; LIPID; NFE2L2 PROTEIN, HUMAN; NQO1 PROTEIN, HUMAN; TXNIP PROTEIN, HUMAN;

ARTICLE; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC PATIENT; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MESTIZO; MEXICAN; OBESITY; ADULT; ANALYSIS; BLOOD; CHI SQUARE DISTRIBUTION; ENZYMOLOGY; ETHNOLOGY; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MEXICO; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OXIDATIVE STRESS; PHENOTYPE; PROTECTION; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

ADULT; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEME OXYGENASE-1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; LOGISTIC MODELS; MALE; MEXICO; MIDDLE AGED; MULTIVARIATE ANALYSIS; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; OBESITY; ODDS RATIO; OXIDATIVE STRESS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTECTIVE FACTORS; RISK FACTORS; SEX FACTORS;

EID: 84971224750     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2017/7543194     Document Type: Erratum

References (39)

1. International Diabetes Federation, Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 7th edition, 2015, http://www. diabetesatlas. org.
2. R. H. Eckel, S. E. Kahn, E. Ferrannini et al., "Obesity and type 2 diabetes: what can be unified and what needs to be individualized" Diabetes Care, vol. 34, no. 6, pp. 1424-1430, 2011.
3. S. Tyrovolas, A. Koyanagi, N. Garinet al., "Diabetesmellitus and its association with central obesity and disability among older adults: A global perspective, " Experimental Gerontology, vol. 64, pp. 70-77, 2015.
4. M. Serrano-Rios, "Relationship between obesity and the increased risk of major complications in non-insulin-dependent diabetesmellitus, " European Journal of Clinical Investigation, vol. 28, supplement 2, pp. 14-18, 1998.
5. S.-I. Yamagishi, S. Maeda, T. Matsui, S. Ueda, K. Fukami, and S. Okuda, "Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes, " Biochimica et Biophysica Acta-General Subjects, vol. 1820, no. 5, pp. 663-671, 2012.
6. Y.-J. Surh, J. K. Kundu, and H.-K. Na, "Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals, " Planta Medica, vol. 74, no. 13, pp. 1526-1539, 2008.
7. X. Wang, H. Chen, J. Liu et al., "Association between the NF-E2 related factor 2 gene polymorphism and oxidative stress, antioxidative status, and newly-diagnosed type 2 diabetes mellitus in a Chinese population, " International Journal of Molecular Sciences, vol. 16, no. 7, pp. 16483-16496, 2015.
8. A. S. Jiménez-Osorio, A. Picazo, S. González-Reyes, D. Barrera-Oviedo, M. E. Rodríguez-Arellano, and J. Pedraza-Chaverri, "Nrf2 and redox status in prediabetic and diabetic patients, " International Journal of Molecular Sciences, vol. 15, no. 11, pp. 20290-20305, 2014.
9. J. Pi, L. Leung, P. Xue et al., "Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity, " The Journal of Biological Chemistry, vol. 285, no. 12, pp. 9292-9300, 2010.
10. H.-Y. Cho, "Genomic structure and variation of nuclear factor (erythroid-derived 2)-like 2, " Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 286524, 24 pages, 2013.
11. Y. Shimoyama, Y. Mitsuda, N. Hamajima, and T. Niwa, "Polymorphisms of Nrf2, an antioxidative gene, are associated with blood pressure in Japanese, " Nagoya Journal of Medical Science, vol. 76, no. 1-2, pp. 113-120, 2014.
12. S. M. Figarska, J. M. Vonk, and H. M. Boezen, "NFE2L2 polymorphisms, mortality, and metabolism in the general population, " Physiological Genomics, vol. 46, no. 12, pp. 411-417, 2014.
13. D. Ross and D. Siegel, "NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics, " Methods in Enzymology, vol. 382, pp. 115-144, 2004.
14. J.-E. Chung, B. C. Chang, K. E. Lee, J. H. Kim, and H. S. Gwak, "Effects ofNAD(P)H quinone oxidoreductase 1 polymorphisms on stable warfarin doses in Korean patients with mechanical cardiac valves, " European Journal of Clinical Pharmacology, vol. 71, no. 10, pp. 1229-1236, 2015.
15. H.-Y. Shyu, C.-S. Fong, Y.-P. Fu et al., "Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke, " Clinica Chimica Acta, vol. 411, no. 11-12, pp. 840-845, 2010.
16. S. J. Han, E. S. Kang, H. J. Kim et al., "The C609T variant of NQO1 is associated with carotid artery plaques in patients with type 2 diabetes, "Molecular Genetics andMetabolism, vol. 97, no. 1, pp. 85-90, 2009.
17. T. Ramprasath, P. S. Murugan, E. Kalaiarasan, P. Gomathi, A. Rathinavel, and G. S. Selvam, "Genetic association of Glutathione peroxidase-1 (GPx-1) and NAD(P)H:quinone oxidoreductase 1(NQO1) variants and their association of CAD in patients with type-2 diabetes, "Molecular and Cellular Biochemistry, vol. 361, no. 1-2, pp. 143-150, 2012.
18. A. Martínez-Hernández, E. J. Córdova, O. Rosillo-Salazar et al., "Association of HMOX1 and NQO1 polymorphisms with metabolic syndrome components, " PLoS ONE, vol. 10, no. 5, Article ID e0123313, 2015.
19. E. Y. Lee, Y. H. Lee, S. H. Kim et al., "Association between heme oxygenase-1 promoter polymorphisms and the development of albuminuria in type 2 diabetes: A case-control study, " Medicine, vol. 94, no. 43, article e1825, 2015.
20. R. Lin, W. Fu, W. Zhou et al., "Association of heme oxygenase-1 gene polymorphisms with essential hypertension and blood pressure in the Chinese Han population, " Genetic Testing and Molecular Biomarkers, vol. 15, no. 1-2, pp. 23-28, 2011.
21. E. Junn, S. H. Han, J. Y. Imet al., "Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function, " The Journal of Immunology, vol. 164, no. 12, pp. 6287-6295, 2000.
22. X. He and Q. Ma, "Redox regulation by nuclear factor erythroid 2-related factor 2: gatekeeping for the basal and diabetesinduced expression of thioredoxin-interacting protein, " Molecular Pharmacology, vol. 82, no. 5, pp. 887-897, 2012.
23. M. M. J. van Greevenbroek, V. M. M.-J. Vermeulen, E. J. M. Feskens et al., "Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus, " Diabetic Medicine, vol. 24, no. 5, pp. 498-504, 2007.
24. N. E. Ferreira, S. Omae, A. Pereira et al., "Thioredoxin interacting protein genetic variation is associated with diabetes and hypertension in the Brazilian general population, " Atherosclerosis, vol. 221, no. 1, pp. 131-136, 2012.
25. J. Grimberg, S. Nawoschik, L. Belluscio, R. McKee, A. Turck, and A. Eisenberg, "A simple and efficient non-organic procedure for the isolation of genomic DNA from blood, " Nucleic Acids Research, vol. 17, no. 20, p. 8390, 1989.
26. J. Zúñiga, N. Yu, R. Barquera et al., "HLA class I and class II conserved extended haplotypes and their fragments or blocks in mexicans: implications for the study of genetic diversity in admixed populations, " PLoS ONE, vol. 8, no. 9, Article ID e74442, 2013.
27. P. Sanz, V. Prieto, I. Flores, Y. Torres, M. López-Soto, and M. J. Farfán, "Population data of 13 STRS in southern Spain (Andalusia), " Forensic Science International, vol. 119, no. 1, pp. 113-115, 2001.
28. P. Calzada, I. Suárez, S. García et al., "The Fang population of Equatorial Guinea characterised by 15 STR-PCR polymorphisms, " International Journal of Legal Medicine, vol. 119, no. 2, pp. 107-110, 2005.
29. C. Barrot, C. Sánchez, M. Ortega et al., "Characterisation of three Amerindian populations from Hidalgo State (Mexico) by 15 STR-PCR polymorphisms, " International Journal of Legal Medicine, vol. 119, no. 2, pp. 111-115, 2005.
30. A. González-Martín, A. Gorostiza, H. Rangel-Villalobos et al., "Analyzing the genetic structure of the Tepehua in relation to other neighbouring Mesoamerican populations. A study based on allele frequencies of STR markers, " American Journal of Human Biology, vol. 20, no. 5, pp. 605-613, 2008.
31. Y. Tan, T. Ichikawa, J. Li et al., "Diabetic downregulation ofNrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo, " Diabetes, vol. 60, no. 2, pp. 625-633, 2011.
32. H.-A. Seo and I.-K. Lee, "The role of NRF2: Adipocyte differentiation, obesity, and insulin resistance, " Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 184598, 7 pages, 2013.
33. J. Xu, A. C. Donepudi, V. R. More et al., "Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in leptin-deficient mice, " Obesity, vol. 23, no. 2, pp. 335-344, 2015.
34. A. Uruno, Y. Yagishita, and M. Yamamoto, "The Keap1-Nrf2 system and diabetes mellitus, " Archives of Biochemistry and Biophysics, vol. 566, pp. 76-84, 2015.
35. G. Wang, L. Zhang, and Q. Li, "Genetic polymorphisms of GSTT1, GSTM1, and NQO1 genes and diabetes mellitus risk in Chinese population, " Biochemical and Biophysical Research Communications, vol. 341, no. 2, pp. 310-313, 2006.
36. D. Kim, "An association between 609 CT Polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) gene and blood glucose levels in Korean population, " Korean Diabetes Journal, vol. 33, no. 1, pp. 24-30, 2009.
37. S. K. Das, N. K. Sharma, S. J. Hasstedt et al., "An integrative genomics approach identifies activation of thioredoxin/ thioredoxin reductase-1-mediated oxidative stress defense pathway and inhibition of angiogenesis in obese nondiabetic human subjects, " The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 8, pp. E1308-E1313, 2011.
38. G. Tanaka, F. Aminuddin, L. Akhabir et al., "Effect of heme oxygenase-1 polymorphisms on lung function and gene expression, " BMC Medical Genetics, vol. 12, article 117, 2011.
39. Y. Shimoyama, Y. Mitsuda, Y. Tsuruta, N. Hamajima, and T. Niwa, "Polymorphism of Nrf2, an antioxidative gene, is associated with blood pressure and cardiovascular mortality in hemodialysis patients, " International Journal of Medical Sciences, vol. 11, no. 7, pp. 726-731, 2014.